nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—TLR4—multiple sclerosis	0.0152	0.889	CrCbGaD
Nalbuphine—OPRM1—nerve—multiple sclerosis	0.00789	0.215	CbGeAlD
Nalbuphine—OPRM1—brainstem—multiple sclerosis	0.00338	0.0925	CbGeAlD
Nalbuphine—OPRD1—nervous system—multiple sclerosis	0.0026	0.0711	CbGeAlD
Nalbuphine—OPRD1—central nervous system—multiple sclerosis	0.0025	0.0684	CbGeAlD
Nalbuphine—OPRK1—nervous system—multiple sclerosis	0.00249	0.0681	CbGeAlD
Nalbuphine—OPRK1—central nervous system—multiple sclerosis	0.0024	0.0656	CbGeAlD
Nalbuphine—OPRK1—cerebellum—multiple sclerosis	0.00235	0.0641	CbGeAlD
Nalbuphine—Body temperature increased—Cladribine—multiple sclerosis	0.0022	0.00366	CcSEcCtD
Nalbuphine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.0022	0.00365	CcSEcCtD
Nalbuphine—OPRM1—midbrain—multiple sclerosis	0.00216	0.0589	CbGeAlD
Nalbuphine—Bradycardia—Prednisolone—multiple sclerosis	0.00215	0.00357	CcSEcCtD
Nalbuphine—Sweating increased—Betamethasone—multiple sclerosis	0.00215	0.00357	CcSEcCtD
Nalbuphine—Sweating increased—Dexamethasone—multiple sclerosis	0.00215	0.00357	CcSEcCtD
Nalbuphine—Hypotension—Azathioprine—multiple sclerosis	0.00212	0.00352	CcSEcCtD
Nalbuphine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00212	0.00351	CcSEcCtD
Nalbuphine—Cardiac arrest—Prednisone—multiple sclerosis	0.00211	0.00351	CcSEcCtD
Nalbuphine—OPRM1—spinal cord—multiple sclerosis	0.0021	0.0575	CbGeAlD
Nalbuphine—Hypersensitivity—Cladribine—multiple sclerosis	0.00205	0.00341	CcSEcCtD
Nalbuphine—Asthenia—Cladribine—multiple sclerosis	0.002	0.00332	CcSEcCtD
Nalbuphine—OPRD1—brain—multiple sclerosis	0.00199	0.0543	CbGeAlD
Nalbuphine—Bradycardia—Triamcinolone—multiple sclerosis	0.00198	0.00329	CcSEcCtD
Nalbuphine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00198	0.00328	CcSEcCtD
Nalbuphine—Pruritus—Cladribine—multiple sclerosis	0.00197	0.00327	CcSEcCtD
Nalbuphine—Convulsion—Mitoxantrone—multiple sclerosis	0.00194	0.00323	CcSEcCtD
Nalbuphine—Hypertension—Mitoxantrone—multiple sclerosis	0.00194	0.00322	CcSEcCtD
Nalbuphine—Hallucination—Methylprednisolone—multiple sclerosis	0.00193	0.00321	CcSEcCtD
Nalbuphine—OPRK1—brain—multiple sclerosis	0.00191	0.0521	CbGeAlD
Nalbuphine—Anxiety—Mitoxantrone—multiple sclerosis	0.0019	0.00316	CcSEcCtD
Nalbuphine—Naloxone—ALB—multiple sclerosis	0.00189	0.111	CrCbGaD
Nalbuphine—Sweating increased—Prednisone—multiple sclerosis	0.00187	0.00311	CcSEcCtD
Nalbuphine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00187	0.0031	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00185	0.00308	CcSEcCtD
Nalbuphine—Confusional state—Mitoxantrone—multiple sclerosis	0.00185	0.00307	CcSEcCtD
Nalbuphine—Dizziness—Cladribine—multiple sclerosis	0.00184	0.00306	CcSEcCtD
Nalbuphine—Erythema—Prednisolone—multiple sclerosis	0.00184	0.00306	CcSEcCtD
Nalbuphine—Oedema—Mitoxantrone—multiple sclerosis	0.00183	0.00304	CcSEcCtD
Nalbuphine—Shock—Mitoxantrone—multiple sclerosis	0.0018	0.00299	CcSEcCtD
Nalbuphine—Bradycardia—Betamethasone—multiple sclerosis	0.0018	0.00298	CcSEcCtD
Nalbuphine—Bradycardia—Dexamethasone—multiple sclerosis	0.0018	0.00298	CcSEcCtD
Nalbuphine—Abdominal pain—Azathioprine—multiple sclerosis	0.00179	0.00297	CcSEcCtD
Nalbuphine—Body temperature increased—Azathioprine—multiple sclerosis	0.00179	0.00297	CcSEcCtD
Nalbuphine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00179	0.00297	CcSEcCtD
Nalbuphine—OPRM1—nervous system—multiple sclerosis	0.00177	0.0485	CbGeAlD
Nalbuphine—Vomiting—Cladribine—multiple sclerosis	0.00177	0.00294	CcSEcCtD
Nalbuphine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00177	0.00294	CcSEcCtD
Nalbuphine—Rash—Cladribine—multiple sclerosis	0.00176	0.00292	CcSEcCtD
Nalbuphine—Hallucination—Betamethasone—multiple sclerosis	0.00176	0.00292	CcSEcCtD
Nalbuphine—Hallucination—Dexamethasone—multiple sclerosis	0.00176	0.00292	CcSEcCtD
Nalbuphine—Dermatitis—Cladribine—multiple sclerosis	0.00176	0.00291	CcSEcCtD
Nalbuphine—Headache—Cladribine—multiple sclerosis	0.00175	0.0029	CcSEcCtD
Nalbuphine—Vision blurred—Prednisolone—multiple sclerosis	0.00174	0.00288	CcSEcCtD
Nalbuphine—Hypotension—Mitoxantrone—multiple sclerosis	0.00171	0.00284	CcSEcCtD
Nalbuphine—OPRM1—central nervous system—multiple sclerosis	0.00171	0.0467	CbGeAlD
Nalbuphine—Depression—Prednisone—multiple sclerosis	0.00171	0.00283	CcSEcCtD
Nalbuphine—Erythema—Triamcinolone—multiple sclerosis	0.00169	0.00281	CcSEcCtD
Nalbuphine—Erythema—Methylprednisolone—multiple sclerosis	0.00169	0.0028	CcSEcCtD
Nalbuphine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00167	0.00277	CcSEcCtD
Nalbuphine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00166	0.00275	CcSEcCtD
Nalbuphine—Nausea—Cladribine—multiple sclerosis	0.00166	0.00275	CcSEcCtD
Nalbuphine—Vertigo—Prednisolone—multiple sclerosis	0.00165	0.00275	CcSEcCtD
Nalbuphine—Syncope—Prednisolone—multiple sclerosis	0.00165	0.00274	CcSEcCtD
Nalbuphine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00164	0.00273	CcSEcCtD
Nalbuphine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00163	0.00271	CcSEcCtD
Nalbuphine—Somnolence—Mitoxantrone—multiple sclerosis	0.00163	0.0027	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00162	0.00269	CcSEcCtD
Nalbuphine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00161	0.00268	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—multiple sclerosis	0.0016	0.00266	CcSEcCtD
Nalbuphine—Convulsion—Prednisolone—multiple sclerosis	0.0016	0.00265	CcSEcCtD
Nalbuphine—Hypertension—Prednisolone—multiple sclerosis	0.00159	0.00264	CcSEcCtD
Nalbuphine—Bradycardia—Prednisone—multiple sclerosis	0.00156	0.0026	CcSEcCtD
Nalbuphine—Erythema—Dexamethasone—multiple sclerosis	0.00154	0.00255	CcSEcCtD
Nalbuphine—Erythema—Betamethasone—multiple sclerosis	0.00154	0.00255	CcSEcCtD
Nalbuphine—Hallucination—Prednisone—multiple sclerosis	0.00153	0.00254	CcSEcCtD
Nalbuphine—Vertigo—Triamcinolone—multiple sclerosis	0.00152	0.00253	CcSEcCtD
Nalbuphine—Syncope—Triamcinolone—multiple sclerosis	0.00152	0.00252	CcSEcCtD
Nalbuphine—Vertigo—Methylprednisolone—multiple sclerosis	0.00152	0.00252	CcSEcCtD
Nalbuphine—Syncope—Methylprednisolone—multiple sclerosis	0.00152	0.00252	CcSEcCtD
Nalbuphine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00151	0.00251	CcSEcCtD
Nalbuphine—Oedema—Prednisolone—multiple sclerosis	0.0015	0.00249	CcSEcCtD
Nalbuphine—Dizziness—Azathioprine—multiple sclerosis	0.0015	0.00249	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.0015	0.00249	CcSEcCtD
Nalbuphine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00149	0.00247	CcSEcCtD
Nalbuphine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00149	0.00247	CcSEcCtD
Nalbuphine—Shock—Prednisolone—multiple sclerosis	0.00148	0.00245	CcSEcCtD
Nalbuphine—Convulsion—Triamcinolone—multiple sclerosis	0.00147	0.00244	CcSEcCtD
Nalbuphine—Tachycardia—Prednisolone—multiple sclerosis	0.00147	0.00243	CcSEcCtD
Nalbuphine—Convulsion—Methylprednisolone—multiple sclerosis	0.00146	0.00243	CcSEcCtD
Nalbuphine—Hypertension—Triamcinolone—multiple sclerosis	0.00146	0.00243	CcSEcCtD
Nalbuphine—Hypertension—Methylprednisolone—multiple sclerosis	0.00146	0.00242	CcSEcCtD
Nalbuphine—Urticaria—Mitoxantrone—multiple sclerosis	0.00146	0.00242	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00145	0.00241	CcSEcCtD
Nalbuphine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00145	0.0024	CcSEcCtD
Nalbuphine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00145	0.0024	CcSEcCtD
Nalbuphine—Vomiting—Azathioprine—multiple sclerosis	0.00144	0.00239	CcSEcCtD
Nalbuphine—Anxiety—Methylprednisolone—multiple sclerosis	0.00143	0.00238	CcSEcCtD
Nalbuphine—Rash—Azathioprine—multiple sclerosis	0.00143	0.00237	CcSEcCtD
Nalbuphine—Dermatitis—Azathioprine—multiple sclerosis	0.00143	0.00237	CcSEcCtD
Nalbuphine—Depression—Methotrexate—multiple sclerosis	0.00143	0.00237	CcSEcCtD
Nalbuphine—Flushing—Prednisone—multiple sclerosis	0.00143	0.00237	CcSEcCtD
Nalbuphine—Headache—Azathioprine—multiple sclerosis	0.00142	0.00236	CcSEcCtD
Nalbuphine—Dry mouth—Triamcinolone—multiple sclerosis	0.00141	0.00234	CcSEcCtD
Nalbuphine—Confusional state—Methylprednisolone—multiple sclerosis	0.00139	0.00231	CcSEcCtD
Nalbuphine—Oedema—Triamcinolone—multiple sclerosis	0.00138	0.00229	CcSEcCtD
Nalbuphine—Vertigo—Dexamethasone—multiple sclerosis	0.00138	0.00229	CcSEcCtD
Nalbuphine—Vertigo—Betamethasone—multiple sclerosis	0.00138	0.00229	CcSEcCtD
Nalbuphine—Syncope—Betamethasone—multiple sclerosis	0.00138	0.00229	CcSEcCtD
Nalbuphine—Syncope—Dexamethasone—multiple sclerosis	0.00138	0.00229	CcSEcCtD
Nalbuphine—Shock—Triamcinolone—multiple sclerosis	0.00136	0.00226	CcSEcCtD
Nalbuphine—Shock—Methylprednisolone—multiple sclerosis	0.00136	0.00225	CcSEcCtD
Nalbuphine—OPRM1—brain—multiple sclerosis	0.00136	0.037	CbGeAlD
Nalbuphine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00135	0.00224	CcSEcCtD
Nalbuphine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00135	0.00224	CcSEcCtD
Nalbuphine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00135	0.00224	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisolone—multiple sclerosis	0.00135	0.00224	CcSEcCtD
Nalbuphine—Tachycardia—Triamcinolone—multiple sclerosis	0.00135	0.00224	CcSEcCtD
Nalbuphine—Nausea—Azathioprine—multiple sclerosis	0.00135	0.00223	CcSEcCtD
Nalbuphine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00135	0.00223	CcSEcCtD
Nalbuphine—Erythema—Prednisone—multiple sclerosis	0.00134	0.00222	CcSEcCtD
Nalbuphine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00134	0.00222	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00133	0.00221	CcSEcCtD
Nalbuphine—Convulsion—Betamethasone—multiple sclerosis	0.00133	0.00221	CcSEcCtD
Nalbuphine—Convulsion—Dexamethasone—multiple sclerosis	0.00133	0.00221	CcSEcCtD
Nalbuphine—Hypertension—Dexamethasone—multiple sclerosis	0.00133	0.0022	CcSEcCtD
Nalbuphine—Hypertension—Betamethasone—multiple sclerosis	0.00133	0.0022	CcSEcCtD
Nalbuphine—Asthenia—Mitoxantrone—multiple sclerosis	0.00131	0.00218	CcSEcCtD
Nalbuphine—Anxiety—Dexamethasone—multiple sclerosis	0.0013	0.00216	CcSEcCtD
Nalbuphine—Anxiety—Betamethasone—multiple sclerosis	0.0013	0.00216	CcSEcCtD
Nalbuphine—Hypotension—Methylprednisolone—multiple sclerosis	0.00129	0.00214	CcSEcCtD
Nalbuphine—Vision blurred—Prednisone—multiple sclerosis	0.00126	0.00209	CcSEcCtD
Nalbuphine—Oedema—Betamethasone—multiple sclerosis	0.00125	0.00208	CcSEcCtD
Nalbuphine—Oedema—Dexamethasone—multiple sclerosis	0.00125	0.00208	CcSEcCtD
Nalbuphine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00124	0.00206	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00124	0.00206	CcSEcCtD
Nalbuphine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00124	0.00206	CcSEcCtD
Nalbuphine—Shock—Betamethasone—multiple sclerosis	0.00123	0.00205	CcSEcCtD
Nalbuphine—Shock—Dexamethasone—multiple sclerosis	0.00123	0.00205	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00123	0.00205	CcSEcCtD
Nalbuphine—Agitation—Prednisone—multiple sclerosis	0.00123	0.00204	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—multiple sclerosis	0.00122	0.00203	CcSEcCtD
Nalbuphine—Tachycardia—Betamethasone—multiple sclerosis	0.00122	0.00203	CcSEcCtD
Nalbuphine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00122	0.00202	CcSEcCtD
Nalbuphine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00121	0.00202	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00121	0.00201	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00121	0.00201	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—multiple sclerosis	0.0012	0.002	CcSEcCtD
Nalbuphine—Syncope—Prednisone—multiple sclerosis	0.0012	0.00199	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—multiple sclerosis	0.00119	0.00198	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisone—multiple sclerosis	0.00118	0.00195	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—multiple sclerosis	0.00117	0.00195	CcSEcCtD
Nalbuphine—Hypotension—Dexamethasone—multiple sclerosis	0.00117	0.00195	CcSEcCtD
Nalbuphine—Vomiting—Mitoxantrone—multiple sclerosis	0.00116	0.00193	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—multiple sclerosis	0.00116	0.00192	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—multiple sclerosis	0.00116	0.00192	CcSEcCtD
Nalbuphine—Rash—Mitoxantrone—multiple sclerosis	0.00115	0.00192	CcSEcCtD
Nalbuphine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00115	0.00192	CcSEcCtD
Nalbuphine—Headache—Mitoxantrone—multiple sclerosis	0.00115	0.00191	CcSEcCtD
Nalbuphine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00114	0.00189	CcSEcCtD
Nalbuphine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00114	0.00189	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—multiple sclerosis	0.00114	0.00188	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00113	0.00187	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—multiple sclerosis	0.00113	0.00187	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00113	0.00187	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—multiple sclerosis	0.00112	0.00186	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00111	0.00184	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—multiple sclerosis	0.0011	0.00183	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—multiple sclerosis	0.0011	0.00183	CcSEcCtD
Nalbuphine—Urticaria—Triamcinolone—multiple sclerosis	0.0011	0.00182	CcSEcCtD
Nalbuphine—Urticaria—Methylprednisolone—multiple sclerosis	0.0011	0.00182	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—multiple sclerosis	0.0011	0.00182	CcSEcCtD
Nalbuphine—Body temperature increased—Triamcinolone—multiple sclerosis	0.00109	0.00181	CcSEcCtD
Nalbuphine—Oedema—Prednisone—multiple sclerosis	0.00109	0.00181	CcSEcCtD
Nalbuphine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00109	0.00181	CcSEcCtD
Nalbuphine—Nausea—Mitoxantrone—multiple sclerosis	0.00109	0.00181	CcSEcCtD
Nalbuphine—Shock—Prednisone—multiple sclerosis	0.00107	0.00178	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—multiple sclerosis	0.00107	0.00177	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—multiple sclerosis	0.00106	0.00175	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—multiple sclerosis	0.00105	0.00175	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00103	0.00172	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00103	0.00172	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00103	0.0017	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00103	0.0017	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00102	0.00169	CcSEcCtD
Nalbuphine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00102	0.00169	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—multiple sclerosis	0.001	0.00167	CcSEcCtD
Nalbuphine—Urticaria—Betamethasone—multiple sclerosis	0.000996	0.00165	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—multiple sclerosis	0.000996	0.00165	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—multiple sclerosis	0.000994	0.00165	CcSEcCtD
Nalbuphine—Asthenia—Triamcinolone—multiple sclerosis	0.000992	0.00165	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000991	0.00165	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—multiple sclerosis	0.000991	0.00165	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—multiple sclerosis	0.000991	0.00165	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000991	0.00165	CcSEcCtD
Nalbuphine—Asthenia—Methylprednisolone—multiple sclerosis	0.000989	0.00164	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—multiple sclerosis	0.000981	0.00163	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—multiple sclerosis	0.000978	0.00162	CcSEcCtD
Nalbuphine—Pruritus—Methylprednisolone—multiple sclerosis	0.000976	0.00162	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—multiple sclerosis	0.000969	0.00161	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—multiple sclerosis	0.000961	0.0016	CcSEcCtD
Nalbuphine—Rash—Prednisolone—multiple sclerosis	0.000948	0.00157	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—multiple sclerosis	0.000947	0.00157	CcSEcCtD
Nalbuphine—Headache—Prednisolone—multiple sclerosis	0.000941	0.00156	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—multiple sclerosis	0.00092	0.00153	CcSEcCtD
Nalbuphine—Dizziness—Triamcinolone—multiple sclerosis	0.000914	0.00152	CcSEcCtD
Nalbuphine—Dizziness—Methylprednisolone—multiple sclerosis	0.000912	0.00151	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—multiple sclerosis	0.0009	0.00149	CcSEcCtD
Nalbuphine—Asthenia—Dexamethasone—multiple sclerosis	0.0009	0.00149	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—multiple sclerosis	0.0009	0.00149	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000893	0.00148	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—multiple sclerosis	0.000893	0.00148	CcSEcCtD
Nalbuphine—Pruritus—Dexamethasone—multiple sclerosis	0.000887	0.00147	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—multiple sclerosis	0.000887	0.00147	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000882	0.00146	CcSEcCtD
Nalbuphine—Vomiting—Triamcinolone—multiple sclerosis	0.000879	0.00146	CcSEcCtD
Nalbuphine—Vomiting—Methylprednisolone—multiple sclerosis	0.000877	0.00146	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—multiple sclerosis	0.000871	0.00145	CcSEcCtD
Nalbuphine—Dermatitis—Triamcinolone—multiple sclerosis	0.000871	0.00145	CcSEcCtD
Nalbuphine—Rash—Methylprednisolone—multiple sclerosis	0.000869	0.00144	CcSEcCtD
Nalbuphine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000869	0.00144	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—multiple sclerosis	0.000868	0.00144	CcSEcCtD
Nalbuphine—Headache—Triamcinolone—multiple sclerosis	0.000866	0.00144	CcSEcCtD
Nalbuphine—Headache—Methylprednisolone—multiple sclerosis	0.000864	0.00143	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—multiple sclerosis	0.000863	0.00143	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—multiple sclerosis	0.000863	0.00143	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—multiple sclerosis	0.000853	0.00142	CcSEcCtD
Nalbuphine—Dizziness—Dexamethasone—multiple sclerosis	0.000829	0.00138	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—multiple sclerosis	0.000829	0.00138	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—multiple sclerosis	0.000821	0.00136	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—multiple sclerosis	0.00082	0.00136	CcSEcCtD
Nalbuphine—Nausea—Methylprednisolone—multiple sclerosis	0.000819	0.00136	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—multiple sclerosis	0.000814	0.00135	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—multiple sclerosis	0.000811	0.00135	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—multiple sclerosis	0.000805	0.00134	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—multiple sclerosis	0.000803	0.00133	CcSEcCtD
Nalbuphine—Vomiting—Dexamethasone—multiple sclerosis	0.000797	0.00132	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—multiple sclerosis	0.000797	0.00132	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—multiple sclerosis	0.000791	0.00131	CcSEcCtD
Nalbuphine—Rash—Betamethasone—multiple sclerosis	0.000791	0.00131	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—multiple sclerosis	0.00079	0.00131	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—multiple sclerosis	0.00079	0.00131	CcSEcCtD
Nalbuphine—OPRD1—GPCR ligand binding—CNR1—multiple sclerosis	0.000786	0.00228	CbGpPWpGaD
Nalbuphine—Headache—Betamethasone—multiple sclerosis	0.000786	0.0013	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—multiple sclerosis	0.000786	0.0013	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—multiple sclerosis	0.000784	0.0013	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—RGS1—multiple sclerosis	0.000782	0.00227	CbGpPWpGaD
Nalbuphine—Pruritus—Prednisone—multiple sclerosis	0.000773	0.00128	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000767	0.00223	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000765	0.00222	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000755	0.00219	CbGpPWpGaD
Nalbuphine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000752	0.00125	CcSEcCtD
Nalbuphine—OPRM1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00075	0.00218	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000747	0.00217	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000747	0.00217	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR2—multiple sclerosis	0.000746	0.00217	CbGpPWpGaD
Nalbuphine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000746	0.00124	CcSEcCtD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000745	0.00217	CbGpPWpGaD
Nalbuphine—Nausea—Betamethasone—multiple sclerosis	0.000745	0.00124	CcSEcCtD
Nalbuphine—Nausea—Dexamethasone—multiple sclerosis	0.000745	0.00124	CcSEcCtD
Nalbuphine—OPRD1—Signaling by GPCR—GPR65—multiple sclerosis	0.000741	0.00215	CbGpPWpGaD
Nalbuphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000737	0.00214	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000736	0.00214	CbGpPWpGaD
Nalbuphine—Urticaria—Methotrexate—multiple sclerosis	0.000725	0.0012	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—multiple sclerosis	0.000722	0.0012	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—multiple sclerosis	0.000721	0.0012	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—multiple sclerosis	0.000721	0.0012	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00072	0.00209	CbGpPWpGaD
Nalbuphine—OPRK1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00072	0.00209	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LINGO1—multiple sclerosis	0.000717	0.00208	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000716	0.00208	CbGpPWpGaD
Nalbuphine—OPRD1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000708	0.00206	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000707	0.00206	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000701	0.00204	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL3—multiple sclerosis	0.000698	0.00203	CbGpPWpGaD
Nalbuphine—OPRM1—Opioid Signalling—MAPK1—multiple sclerosis	0.000696	0.00202	CbGpPWpGaD
Nalbuphine—Vomiting—Prednisone—multiple sclerosis	0.000694	0.00115	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CNR1—multiple sclerosis	0.000689	0.002	CbGpPWpGaD
Nalbuphine—Rash—Prednisone—multiple sclerosis	0.000689	0.00114	CcSEcCtD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000688	0.002	CbGpPWpGaD
Nalbuphine—Dermatitis—Prednisone—multiple sclerosis	0.000688	0.00114	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—RGS1—multiple sclerosis	0.000686	0.00199	CbGpPWpGaD
Nalbuphine—Headache—Prednisone—multiple sclerosis	0.000684	0.00114	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000681	0.00198	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR1—multiple sclerosis	0.000678	0.00197	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000678	0.00197	CbGpPWpGaD
Nalbuphine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000672	0.00112	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000671	0.00195	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000671	0.00195	CbGpPWpGaD
Nalbuphine—Asthenia—Methotrexate—multiple sclerosis	0.000655	0.00109	CcSEcCtD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000655	0.0019	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000655	0.0019	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.000652	0.0019	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GPR65—multiple sclerosis	0.00065	0.00189	CbGpPWpGaD
Nalbuphine—Nausea—Prednisone—multiple sclerosis	0.000649	0.00108	CcSEcCtD
Nalbuphine—OPRM1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000649	0.00189	CbGpPWpGaD
Nalbuphine—Pruritus—Methotrexate—multiple sclerosis	0.000646	0.00107	CcSEcCtD
Nalbuphine—OPRM1—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.00064	0.00186	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000638	0.00186	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000632	0.00184	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCR2—multiple sclerosis	0.000631	0.00183	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LINGO1—multiple sclerosis	0.000629	0.00183	CbGpPWpGaD
Nalbuphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000623	0.00181	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000622	0.00181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TAGAP—multiple sclerosis	0.000621	0.00181	CbGpPWpGaD
Nalbuphine—OPRK1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000621	0.00181	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00062	0.0018	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCL5—multiple sclerosis	0.000609	0.00177	CbGpPWpGaD
Nalbuphine—OPRM1—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.000609	0.00177	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000605	0.00176	CbGpPWpGaD
Nalbuphine—Dizziness—Methotrexate—multiple sclerosis	0.000604	0.001	CcSEcCtD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000594	0.00173	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR1—multiple sclerosis	0.000594	0.00173	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000593	0.00172	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CNR1—multiple sclerosis	0.000582	0.00169	CbGpPWpGaD
Nalbuphine—Vomiting—Methotrexate—multiple sclerosis	0.00058	0.000963	CcSEcCtD
Nalbuphine—OPRM1—Signaling by GPCR—RGS1—multiple sclerosis	0.000579	0.00168	CbGpPWpGaD
Nalbuphine—Rash—Methotrexate—multiple sclerosis	0.000575	0.000955	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—multiple sclerosis	0.000575	0.000954	CcSEcCtD
Nalbuphine—Headache—Methotrexate—multiple sclerosis	0.000572	0.000949	CcSEcCtD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000563	0.00164	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000553	0.00161	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000553	0.00161	CbGpPWpGaD
Nalbuphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000551	0.0016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GPR65—multiple sclerosis	0.000549	0.0016	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCR5—multiple sclerosis	0.000549	0.00159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TAGAP—multiple sclerosis	0.000545	0.00158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—S1PR1—multiple sclerosis	0.000543	0.00158	CbGpPWpGaD
Nalbuphine—Nausea—Methotrexate—multiple sclerosis	0.000542	0.0009	CcSEcCtD
Nalbuphine—OPRK1—GPCR ligand binding—CCL5—multiple sclerosis	0.000534	0.00155	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000534	0.00155	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LINGO1—multiple sclerosis	0.000531	0.00154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GPC5—multiple sclerosis	0.000528	0.00154	CbGpPWpGaD
Nalbuphine—OPRM1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000525	0.00153	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000524	0.00152	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000512	0.00149	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000502	0.00146	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR1—multiple sclerosis	0.000502	0.00146	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000495	0.00144	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000494	0.00144	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—IL6—multiple sclerosis	0.000491	0.00143	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL3—multiple sclerosis	0.000483	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000483	0.0014	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000481	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCR5—multiple sclerosis	0.000481	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—S1PR1—multiple sclerosis	0.000476	0.00138	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000465	0.00135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GPC5—multiple sclerosis	0.000463	0.00135	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RGS1—multiple sclerosis	0.000462	0.00134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000461	0.00134	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000451	0.00131	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000449	0.00131	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000449	0.00131	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000444	0.00129	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GPR65—multiple sclerosis	0.000438	0.00127	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR2—multiple sclerosis	0.000437	0.00127	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000434	0.00126	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—POMC—multiple sclerosis	0.000429	0.00125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL3—multiple sclerosis	0.000424	0.00123	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000422	0.00123	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCL2—multiple sclerosis	0.000419	0.00122	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000417	0.00121	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000408	0.00119	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000408	0.00119	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000407	0.00118	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RGS1—multiple sclerosis	0.000405	0.00118	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CNR1—multiple sclerosis	0.000403	0.00117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000403	0.00117	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL13—multiple sclerosis	0.0004	0.00116	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR1—multiple sclerosis	0.0004	0.00116	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.0004	0.00116	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000394	0.00114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000392	0.00114	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000389	0.00113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GPR65—multiple sclerosis	0.000384	0.00112	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR2—multiple sclerosis	0.000383	0.00111	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000379	0.0011	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—POMC—multiple sclerosis	0.000376	0.00109	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCL2—multiple sclerosis	0.000368	0.00107	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000366	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000363	0.00106	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000358	0.00104	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000357	0.00104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CNR1—multiple sclerosis	0.000354	0.00103	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR1—multiple sclerosis	0.000351	0.00102	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL13—multiple sclerosis	0.000351	0.00102	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000351	0.00102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000345	0.001	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000344	0.001	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000342	0.000995	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000333	0.000968	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000329	0.000957	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000325	0.000943	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000324	0.000941	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000318	0.000925	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000318	0.000924	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	0.000312	0.000908	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000311	0.000904	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00031	0.000901	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000306	0.000888	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000302	0.000877	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000299	0.000869	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000297	0.000863	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000297	0.000863	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000296	0.000861	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	0.000285	0.00083	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	0.000282	0.000818	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000277	0.000807	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	0.000275	0.000799	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	0.000274	0.000797	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000272	0.00079	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PGR—multiple sclerosis	0.000271	0.000786	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000269	0.000782	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000268	0.000779	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	0.000265	0.000771	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD28—multiple sclerosis	0.000263	0.000764	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	0.000258	0.00075	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000255	0.000741	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	0.00025	0.000727	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	0.000247	0.000718	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000243	0.000707	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	0.000242	0.000704	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	0.000241	0.0007	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	0.000238	0.000692	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PGR—multiple sclerosis	0.000237	0.00069	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	0.000233	0.000676	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000232	0.000673	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD28—multiple sclerosis	0.00023	0.00067	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00023	0.000668	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000226	0.000658	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	0.000226	0.000658	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	0.00022	0.00064	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	0.000215	0.000626	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	0.000214	0.000623	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	0.000212	0.000618	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000211	0.000615	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	0.000209	0.000607	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000209	0.000607	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000206	0.000598	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000204	0.000592	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PGR—multiple sclerosis	0.0002	0.000583	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000197	0.000572	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	0.000195	0.000568	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD28—multiple sclerosis	0.000195	0.000566	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	0.000193	0.000561	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000191	0.000556	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	0.000189	0.000549	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	0.000188	0.000547	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD86—multiple sclerosis	0.000188	0.000545	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	0.000185	0.000537	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.00018	0.000522	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	0.000179	0.000521	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000176	0.000513	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	0.000171	0.000498	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	0.000171	0.000497	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	0.000166	0.000483	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD86—multiple sclerosis	0.000164	0.000478	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	0.000164	0.000476	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000163	0.000474	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	0.000163	0.000473	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	0.000162	0.000471	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.00016	0.000464	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000159	0.000462	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	0.000157	0.000457	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—multiple sclerosis	0.000151	0.00044	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	0.00015	0.000436	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	0.000146	0.000424	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000145	0.000421	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	0.000144	0.000418	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	0.000143	0.000415	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD86—multiple sclerosis	0.000139	0.000404	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000137	0.000398	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD80—multiple sclerosis	0.000137	0.000398	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000133	0.000386	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—multiple sclerosis	0.000133	0.000386	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—POMC—multiple sclerosis	0.00013	0.000378	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	0.000127	0.00037	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000127	0.000368	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000124	0.000362	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	0.000123	0.000358	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000121	0.000353	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000121	0.00035	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD80—multiple sclerosis	0.00012	0.000349	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	0.000115	0.000336	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—POMC—multiple sclerosis	0.000114	0.000331	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—multiple sclerosis	0.000112	0.000326	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	0.000112	0.000324	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000109	0.000317	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD80—multiple sclerosis	0.000101	0.000295	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	0.000101	0.000294	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—POMC—multiple sclerosis	9.63e-05	0.00028	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—multiple sclerosis	9.61e-05	0.000279	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	9.56e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	9.42e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	9.22e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	9.09e-05	0.000264	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	8.56e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—multiple sclerosis	8.43e-05	0.000245	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	8.38e-05	0.000244	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	8.09e-05	0.000235	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	7.97e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—multiple sclerosis	7.51e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	7.49e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	7.35e-05	0.000214	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—multiple sclerosis	7.12e-05	0.000207	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	7.09e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	7.09e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	6.74e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—multiple sclerosis	6.59e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	6.57e-05	0.000191	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	6.44e-05	0.000187	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	5.99e-05	0.000174	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—multiple sclerosis	5.65e-05	0.000164	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—multiple sclerosis	5.57e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	5.55e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	5.45e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—multiple sclerosis	4.95e-05	0.000144	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—multiple sclerosis	4.19e-05	0.000122	CbGpPWpGaD
